ACS14 is a derivative of Aspirin. ACS14 reduces Buthionine Sulfoximine (BSO) -induced hypertension, plasma levels of thromboxane B2, 8-isoprostane, and insulin in rats, while GSH remained in the control range. ACS14 can be used for hypertension research [1].
References:
[1]. Rossoni G, et al. Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. Eur J Pharmacol. 2010 Dec 1;648(1-3):139-45.
References:
[1]. Rossoni G, et al. Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. Eur J Pharmacol. 2010 Dec 1;648(1-3):139-45.